- Home
- FOSL vs UNCY Comparison
FOSL vs UNCY Comparison
Compare FOSL & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- UNCY
- Stock Information
- Founded
- FOSL 1984
- UNCY 2016
- Country
- FOSL United States
- UNCY United States
- Employees
- FOSL N/A
- UNCY N/A
- Industry
- FOSL Consumer Specialties
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- FOSL Consumer Discretionary
- UNCY Health Care
- Exchange
- FOSL Nasdaq
- UNCY Nasdaq
- Market Cap
- FOSL 100.0M
- UNCY 91.0M
- IPO Year
- FOSL 1993
- UNCY 2021
- Fundamental
- Price
- FOSL $1.63
- UNCY $4.55
- Analyst Decision
- FOSL Strong Buy
- UNCY Strong Buy
- Analyst Count
- FOSL 1
- UNCY 4
- Target Price
- FOSL $5.00
- UNCY $63.75
- AVG Volume (30 Days)
- FOSL 206.4K
- UNCY 1.5M
- Earning Date
- FOSL 08-07-2025
- UNCY 08-13-2025
- Dividend Yield
- FOSL N/A
- UNCY N/A
- EPS Growth
- FOSL N/A
- UNCY N/A
- EPS
- FOSL N/A
- UNCY N/A
- Revenue
- FOSL $1,123,399,000.00
- UNCY N/A
- Revenue This Year
- FOSL N/A
- UNCY N/A
- Revenue Next Year
- FOSL N/A
- UNCY $1,458.53
- P/E Ratio
- FOSL N/A
- UNCY N/A
- Revenue Growth
- FOSL N/A
- UNCY N/A
- 52 Week Low
- FOSL $0.86
- UNCY $2.02
- 52 Week High
- FOSL $2.61
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- FOSL 63.28
- UNCY 39.53
- Support Level
- FOSL $1.30
- UNCY $4.76
- Resistance Level
- FOSL $1.75
- UNCY $7.15
- Average True Range (ATR)
- FOSL 0.10
- UNCY 0.97
- MACD
- FOSL 0.03
- UNCY -0.28
- Stochastic Oscillator
- FOSL 75.00
- UNCY 7.37
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.